In August this year the British Medical Journal (BMJ) published a critique of the Bryant et al. meta-analyses of trial data on Ivermectin for prevention and treatment of Covid-19. In that critique Popp et al. questioned the integrity of the meta-analysis paper.
Bryant et al. responded saying that the critique “itself contains several misleading items”
You can read the full Bryant et al. response here.